BlackRock’s Theravance Biopharma TBPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $45.7M | Buy |
|
|||||
|
2025
Q1 | $30.8M | Sell |
|
|||||
|
2024
Q4 | $34.9M | Sell |
|
|||||
|
2024
Q3 | $30.1M | Sell |
|
|||||
|
2024
Q2 | $32.1M | Sell |
|
|||||
|
2024
Q1 | $37.7M | Sell |
|
|||||
|
2023
Q4 | $51.6M | Buy |
|
|||||
|
2023
Q3 | $39.4M | Sell |
|
|||||
|
2023
Q2 | $52.6M | Sell |
|
|||||
|
2023
Q1 | $55.8M | Sell |
|
|||||
|
2022
Q4 | $59.8M | Buy |
|
|||||
|
2022
Q3 | $51.8M | Buy |
|
|||||
|
2022
Q2 | $45.5M | Buy |
|
|||||
|
2022
Q1 | $47.1M | Sell |
|
|||||
|
2021
Q4 | $55.3M | Sell |
|
|||||
|
2021
Q3 | $37.8M | Buy |
|
|||||
|
2021
Q2 | $65.6M | Sell |
|
|||||
|
2021
Q1 | $94.6M | Buy |
|
|||||
|
2020
Q4 | $79.8M | Buy |
|
|||||
|
2020
Q3 | $63.9M | Sell |
|
|||||
|
2020
Q2 | $91.9M | Sell |
|
|||||
|
2020
Q1 | $203M | Buy |
|
|||||
|
2019
Q4 | $99.1M | Sell |
|
|||||
|
2019
Q3 | $75.1M | Buy |
|
|||||
|
2019
Q2 | $62.6M | Buy |
|
|||||
|
2019
Q1 | $84.3M | Sell |
|
|||||
|
2018
Q4 | $98.9M | Buy |
|
|||||
|
2018
Q3 | $125M | Buy |
|
|||||
|
2018
Q2 | $85.1M | Buy |
|
|||||
|
2018
Q1 | $86.9M | Sell |
|
|||||
|
2017
Q4 | $104M | Sell |
|
|||||
|
2017
Q3 | $130M | Buy |
|
|||||
|
2017
Q2 | $145M | Buy |
|
|||||
|
2017
Q1 | $129M | Buy |
|
|||||
|
2016
Q4 | $96K | Buy |
|
|||||
|
2016
Q3 | $106K | Sell |
|
|||||
|
2016
Q2 | $87K | Buy |
|
|||||
|
2016
Q1 | $33K | Buy |
|
|||||
|
2015
Q4 | $11K | Hold |
|
|||||
|
2015
Q3 | $8K | Hold |
|
|||||
|
2015
Q2 | $9K | Hold |
|
|||||
|
2015
Q1 | $12K | Hold |
|
|||||
|
2014
Q4 | $10K | Hold |
|
|||||
|
2014
Q3 | $16K | Hold |
|
|||||
|
2014
Q2 | $23K | Buy |
|